• Home
  • Book a Call
  • Latest Funding Rounds
  • Submit your Opportunity
  • Services
  • Latest news
  • Plans & Pricing
  • EU Funding
  • Our HNW & UHNW Network
  • Contact us
  • Team
  • DON VC Network
  • More
    • Home
    • Book a Call
    • Latest Funding Rounds
    • Submit your Opportunity
    • Services
    • Latest news
    • Plans & Pricing
    • EU Funding
    • Our HNW & UHNW Network
    • Contact us
    • Team
    • DON VC Network
  • Home
  • Book a Call
  • Latest Funding Rounds
  • Submit your Opportunity
  • Services
  • Latest news
  • Plans & Pricing
  • EU Funding
  • Our HNW & UHNW Network
  • Contact us
  • Team
  • DON VC Network
DON Therapeutics

Elevate your Healthcare opportunity with DON

Elevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DON

DON Healthcare will be attending

Fierce JPM Week January 14th & 15th, 2025

 With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.  

DON Healthcare Investment dinner held at the Le Meridien Beach Plaza Hotel on the 26th of April 2024


    Video of our DON Investment Event

    Copyright © 2024 DON Therapeutics - All Rights Reserved.


     DON THERAPEUTICS LTD is not a Registered Investment Advisor, Broker/Dealer, Financial Analyst, Financial Bank, Securities Broker or Financial Planner. The Information on this 1. Company email, 2 Company Site, 3 Company LinkedIn is provided for information purposes only. The Information is not intended to be and does not constitute financial advice or any other advice, is general in nature and not specific to you. Before using the Company’s information to make an investment decision, you should seek the advice of a qualified and registered securities professional and undertake your own due diligence. None of the information on our email, website, or LinkedIn is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. The Company is not responsible for any investment decision made by you. You are responsible for your own investment research and investment decisions. 

    • Latest Funding Rounds

    Powered by DON Therapeutics

    This website uses cookies.

    We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

    DeclineAccept